US to authorize Pfizer vaccine for age 12 and up
"The FDA will have to amend the emergency use authorization for the vaccine, but the process should be straightforward," CNN reported.
The US Food and Drug Administration is expected to grant that approval by early next week. After the FDA decision, the Centers for Disease Control and Prevention advisory committee will meet to recommend how the vaccine should be used.
A spokeswoman for the FDA declined to give details on the approval timeline, telling The Washington Post: "We are working to review this request as quickly and transparently as possible."
Further testing on younger children is ongoing.
Moderna is conducting trials of its vaccine in teens, with results expected in the summer, as well as in younger children.
Johnson & Johnson is also planning pediatric trials for its vaccine.
The national vaccination rate peaked around April 11, according to official data, and although 55 percent of US adults now have had one or more doses, there's still a long way to go to achieve population immunity against Covid.
The people most eager to get their shots have, for the most part, already rolled up their sleeves and done so.
Among Republican voters, 29 percent say they will never take the vaccine, compared to five percent of Democrats and nine percent of independents, according to a recent survey by the Kaiser Family Foundation.